Signaling Pathways
Signal transduction pathways constitute a precisely regulated network through which cells perceive external stimuli and initiate intracellular responses. Core research in this field focuses on the mechanisms of molecular signal transmission and regulation within cells and typically encompasses three fundamental stages: signal initiation, signal propagation through cascades, and downstream effector responses. Key molecules—including proteins, nucleic acids, and small molecules—interact with high specificity and are subject to tight regulation (e.g., protein phosphorylation, molecular activation/inhibition). These processes underpin the full spectrum of cellular activities, including proliferation, differentiation, metabolism, apoptosis, and immune responses. While accurate regulation of these pathways is essential for maintaining organismal homeostasis, their dysregulation is a major driver of the onset and progression of diseases such as cancer, neurodegenerative disorders, and autoimmune diseases.
APExBIO is strongly committed to advancing life science research by providing a comprehensive portfolio of small-molecule tools designed to support the elucidation of signaling mechanisms and the identification of key regulatory targets—critical steps for deciphering disease etiology and developing innovative therapies. Our offerings span all major signal transduction pathways, including classical pathways (e.g., PI3K/Akt, MAPK, NF-κB), emerging modalities (e.g., ferroptosis, cuproptosis, pyroptosis), and research on pathway crosstalk. With tens of thousands of products—including inhibitors, activators, and modulators—we robustly support research in oncology, immunology, neuroscience, epigenetics, and other key fields.
Every APExBIO product undergoes rigorous functional validation and purity testing, ensuring suitability for diverse research applications such as pathway mechanism studies, target identification and validation, drug activity evaluation, cell-based assays, and animal model development. We complement our high-quality tools with comprehensive support: each product is supplied with detailed chemical property reports, biological activity data, standardized usage guidelines, and extensive literature citations in high-impact journals. In addition, we provide end-to-end assistance—from product selection and experimental protocol optimization to technical troubleshooting—enabling researchers to rely on tool quality, focus on core scientific questions, and accelerate progress in signal transduction research and translational medicine.
-
BA2871 Thalidomide-5-OHSummary: Thalidomide-5-OH is a Thalidomide-based, protein-recruitable ligand. -
BA2872 PTC-028Summary: PTC-028 is an orally effective inhibitor of stem cell factor for the study of ovarian cancer. -
BA2873 LuxeptinibSummary: Luxeptinib (CG-806) is an orally active, reversible, first-in-class, non-covalent, potent inhibitor. -
BA2874 NHWD-870Summary: NHWD-870 is a potent, orally active and selective inhibitor. -
BA2875 BETd-260Summary: BETd-260 (ZBC260), a PROTAC linked by ligand and ligand-conjugated, was able to reduce protein activity at a low concentration of 30 pM in leukemia cells RS4;11. -
BA2877 SKI-178Summary: SKI-178 is a potent sphingosine kinase-1 and inhibitor. -
BA2879 UBX1325Summary: UBX1325 is an inhibitor that promotes apoptosis in senescent cells. -
BA2880 KinsenosideSummary: Kinsenoside is the main active ingredient isolated from the genus Cleomiscus and possesses a wide range of biological activities and pharmacological effects. -
BA2881 AG-825Summary: AG-825 is a selective, ATP-competitive, inhibitor of tyrosine phosphorylation. -
BA2883 S130Summary: S130 is a high affinity, selective inhibitor of cysteine proteases with a value of 3.24 μM.

